Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Xiaoyun Zhuo"'
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Non-alcoholic fatty liver disease (NAFLD), ranging from non-alcoholic fatty liver to non-alcoholic steatohepatitis, can be prevalent in patients with type 2 diabetes mellitus (T2DM). However, no antidiabetic drug has been approved for the treatment o
Externí odkaz:
https://doaj.org/article/13294dbd20254fb4aaf23c53534abc7d
Autor:
Lishan Li, Shitao Rao, Yanzhen Cheng, Xiaoyun Zhuo, Caihong Deng, Ningning Xu, Hua Zhang, Li Yang
Publikováno v:
MicrobiologyOpen, Vol 8, Iss 8, Pp n/a-n/a (2019)
Abstract The complex relationship between intestinal microbiota and host is a novel field in recent years. A large number of studies are being conducted on the relationship between intestinal microbiota and bone metabolism. Bone metabolism consisted
Externí odkaz:
https://doaj.org/article/dd870a7bb2a04344aae7774f80c917c6
Autor:
Li Yang, Shuang-Li Yang, Wen Xu, Xiaoyun Zhuo, Yanzhen Cheng, Ji-Yu Wang, Shitao Rao, Chuman Lin
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 319:E1019-E1030
Glucagon-like peptide-1 (GLP-1) is a novel antidiabetic agent used in clinical practice. Recently, it was reported to exert a renoprotective effect in the human kidney-2 cells and kidneys of diabetic rats, which was induced by one type of GLP-1 analo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d090e13ea3ecb294313a6c4e4094b8f4
https://doi.org/10.1152/ajpendo.00195.2019
https://doi.org/10.1152/ajpendo.00195.2019
Autor:
Shuang-Li Yang, Hong Chen, Xiaoyun Zhuo, Hua Zhang, Yanzhen Cheng, Ji-Yu Wang, Li Yang, Meng Ye, Li-Tao Wang
Publikováno v:
Life Sciences. 205:184-192
Aims Diabetes-associated osteoporosis is mainly caused by the formation and accumulation of advanced glycation end products (AGEs). Angiotensin II type 1 receptor blocker (ARB) has anabolic bone effects on the physicochemical properties of the bone i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff7ee67239b61b1f4092f1c766ea47d
https://doi.org/10.1016/j.lfs.2018.04.042
https://doi.org/10.1016/j.lfs.2018.04.042
Publikováno v:
SSRN Electronic Journal.
Nonalcoholic fatty liver diseases (NAFLD) ranging from nonalcoholic fatty liver to non-alcoholic steatohepatitis have a high preference in Type 2 diabetes mellitus (T2DM) patients. However, no antidiabetic drug is approved for the treatment of NAFLD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8a2bdce4e718b492ace3d099eb43a1
https://doi.org/10.2139/ssrn.3408048
https://doi.org/10.2139/ssrn.3408048
Autor:
Xiaoyun Zhuo
Publikováno v:
Proceedings of the 2019 International Conference on Pedagogy, Communication and Sociology (ICPCS 2019).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a167b0e448f068931eb5dfc8fc23a1d5
https://doi.org/10.2991/icpcs-19.2019.91
https://doi.org/10.2991/icpcs-19.2019.91
Autor:
Shuangli Yang, Chuman Lin, Xiaoyun Zhuo, Jiyu Wang, Shitao Rao, Wen Xu, Yanzhen Cheng, Li Yang
Publikováno v:
American Journal of Physiology: Endocrinology & Metabolism; Dec2020, Vol. 319 Issue 6, pE1019-E1030, 12p